Journal: JCI Insight
Article Title: CFTR negatively reprograms Th2 cell responses, and CFTR potentiation restrains allergic airway inflammation
doi: 10.1172/jci.insight.191098
Figure Lengend Snippet: ( A ) Reverse transcriptase PCR gel for CFTR mRNA (predicted size of 125 bp; arrow) in Cftr +/+ and Cftr −/− mouse CD4 + T cells. Lane 1 is a 100 bp ladder. ( B ) qPCR analysis of Cftr expression in Cftr +/+ and Cftr −/− mouse CD4 + T cells at 0 and 24 hours following TCR ligation with anti-CD3 and anti-CD28 mAbs ( n = 4 per genotype and time point). ( C ) Immunostaining of CFTR (green), plasma membrane lectin (red), and nuclei (blue) in 24-hour–cultured mouse CD4 + cells (3 different biologic replicates per genotype, Cftr +/+ and Cftr −/− ). Scale bar: 10 μm. ( D ) Immunoprecipitated CFTR protein in immortalized human CD4 + T cells (Jurkat) using UNC-450 anti-CFTR monoclonal antibody (mAb) for pulldown and UNC-596 anti-CFTR mAb for detection compared with immunoprecipitation isotype control. ( E – H ) qPCR analysis of Cftr expression in Cftr +/+ and Cftr −/− cultured mouse CD4 + T cells at 0, 6, 18, 48, 72, and 78 hours in Th2 ( E ), Th1 ( F ), Th17 ( G ), and Tregs ( H ) ( n = 3 per genotype per time point). Dotted lines represent TCR ligation with anti-CD3 (1 μg/mL) and anti-CD28 (0.5 μg/mL) mAbs and (a) anti–IFN-γ (10 μg/mL) and mouse IL-4 (10 ng/mL) for Th2 cells, (b) anti–IL-4 (10 μg/mL) and mouse IL-12 (10 ng/mL) for Th1 cells, and (c) human TGF-β (0.5 ng/mL), mouse IL-23 (10 ng/mL), mouse IL-6 (40 ng/mL), mouse IL-1b (10 ng/mL), anti–IL-4 (10 μg/mL), and anti–IFN-γ (10 μg/mL) for Th17 cells. Tregs were polarized and restimulated with anti-CD3 (1 μg/mL), human IL-2 (100 IU/mL), and recombinant human TGF-β (1ng/mL). Data are shown as mean ± SD. Statistical analysis were done in B and E – H by 1-way ANOVA followed by Tukey’s honestly significant difference (HSD) post hoc test for multiple comparisons. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Article Snippet: The media were supplemented with ImmunoCult Human Th2 Differentiation Supplement (containing recombinant human IL-4 and mouse anti–human IFN-γ, StemCell Technologies) and 100 IU/mL IL-2 (NIH).
Techniques: Reverse Transcription, Expressing, Ligation, Immunostaining, Clinical Proteomics, Membrane, Cell Culture, Immunoprecipitation, Control, Recombinant